Sorrento Therapeutics Sues Biotech Billionaire Patrick Soon-Shiong for Breach of Contract

When biotech billionaire Patrick Soon-Shiong bought Sorrento’s new cancer fighting drug, he might not have had the company’s best interests at heart. At least that’s what CEO of Sorrento, Henry Ji, is alleging in a lawsuit recently filed with the Los Angeles Superior Court...